Qingping Tian

Dr. Qingping Tian

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YSYong-Ping Shi
Yong-Ping Shi
YZYou-Gang Zhang
You-Gang Zhang
HLHao-Nan Li
Hao-Nan Li
HKHao-Tian Kong
Hao-Tian Kong
SZShan-shan Zhang
Shan-shan Zhang
QTQingping Tian
Qingping Tian

1 August 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
DZDi Zhang
Di Zhang
DYDan Ye
Dan Ye
PJPanpan Jing
Panpan Jing
XTXiao Tan
Xiao Tan
LQLixia Qiu
Lixia Qiu
QTQingping Tian
Qingping Tian

24 January 2021 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
FZFeng Zhang
Feng Zhang
LHLiwen Han
Liwen Han
JWJiazhen Wang
Jiazhen Wang
MSMinglei Shu
Minglei Shu
KLKechun Liu
Kechun Liu
QHQiuxia He
Qiuxia He

1 December 2021 in Food Chemistry
Verified
Journal Article
Closed access
DYDan Ye
Dan Ye
LSLiyan Shen
Liyan Shen
YSYing Sun
Ying Sun
DZDi Zhang
Di Zhang
XTXiao Tan
Xiao Tan
QTQingping Tian
Qingping Tian

1 March 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
XLXiaxia Liu
Xiaxia Liu
XKXia Kong
Xia Kong
LXLi Xu
Li Xu
YSYonghui Su
Yonghui Su
SXShanshan Xu
Shanshan Xu
LHLiwen Han
Liwen Han

13 June 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
YQYuchao Qiao
Yuchao Qiao
SKShuhui Kang
Shuhui Kang
YWYijia Wu
Yijia Wu
YCYu Cui
Yu Cui
XWXuchun Wang
Xuchun Wang
LQLixia Qiu
Lixia Qiu
Polycaprolactone microspheres (PCL-MS) are widely used in tissue filling, while particle size and uniformity are crucial for improving filling and therapeutic effects. Efficient optimization methods are essential for accelerating their development. Box-Behnken design was applied to investigate three factors for PCL-MS: PCL concentration (X1), polyvinyl alcohol concentration (X2) and water-oil ratio (WOR,X3). Mathematical models were developed to predict particle size (Y1) and particle size distribution width (Y2). Multi-objective optimization of Y1 and Y2 was performed using the Nondominated Sorting Genetic Algorithm-II (NSGA-II) and the Multi-Objective Artificial Hummingbird Algorithm (MOAHA) to determine the optimal preparation schemes. Experimental validation was conducted to confirm the validity and reliability of the optimization schemes. After multi-objective optimization, two ideal preparation schemes were selected from the Pareto solution sets obtained by NSGA-II and MOAHA, respectively. Experimental validation showed no significant statistical difference (P>0.05) between the measured and predicted values of Y1 and Y2 for scheme 12 and 21 of NSGA-II and scheme 3 of MOAHA, with deviations under 5%. All protocols met target requirements, indicating their suitability for PCL-MS preparation. This study utilized Box-Behnken design and intelligent optimization to develop three alternative PCL-MS formulations, facilitating the production of microspheres with smaller particle sizes and narrower distributions, thereby advancing formulation development.